NTX001 – Socially Bharat

socially bharat
September 20, 2024
3 Mins Read

Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting

Chesterbrook, Pa., United States: Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today

64 Views
0 Comments

socially bharat
September 12, 2024
2 Mins Read

Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair

Chesterbrook, Pa., United States: – Breakthrough Therapy designation for NTX-001 granted by FDA – Preparation is underway for the Phase

60 Views
0 Comments

Socially Bharat is your comprehensive source for Social news, NGO’s, and expert insights from across India.

Quick Links

Contact Us

Stay Updated

Share Your Message!